Biolegend, 100329, APC/Cyanine7 anti-mouse CD3ε Antibody
25microg
Catalog Number: 100329
Loading…
| Verified Reactivity | Mouse |
|---|---|
| Antibody Type | Monoclonal |
| Host Species | Armenian Hamster |
| Immunogen | H-2Kb-specific mouse cytotoxic T lymphocyte clone BM10-37 |
| Formulation | Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide. |
| Preparation | The antibody was purified by affinity chromatography, and conjugated with APC/Cyanine7 under optimal conditions. |
| Concentration | 0.2 mg/ml |
| Storage & Handling | The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze. |
| Application | FC - Quality tested |
| Recommended Usage | Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.5 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application. |
| Excitation Laser | Red Laser (633 nm) |
Unless otherwise stated, the minimum order amount is USD 1,000.
For orders below USD 1,000, an additional handling fee may apply, or we may arrange local delivery / local handover where available.
All quotations are subject to final confirmation, including product availability, lead time, batch information, shipping cost, and applicable export or handling requirements.
For quotation requests, please send an RFQ from website or contact:
Please send inquiries directly to us in the “To” field. Emails sent via BCC, mass mailing, or with unrelated recipients may be automatically filtered and will not be processed.
| Application Notes |
|---|
| Clone 145-2C11 is useful for in vitro blocking of target-specific CTL-mediated cell lysis1, as well as T cell activation assays, inducing proliferation and cytokine production1,2,7,12,16. It also induces apoptosis in immature thymocytes32, and in vivo T cell depletion8-10. Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1, immunohistochemical staining14,15 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, Western blotting4, complement-mediated cytotoxicity6, in vitro and in vivo stimulation of T cells1,2,7,12,16, immunofluorescent staining5, and in vivo T cell depletion8-10. The 145-2C11 antibody has been reported to block the binding of 17A2 antibody to CD3 epsilon-specific T cells11. Clone 145-2C11 is not recommended for formalin-fixed paraffin embedded sections. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 100314). For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 100340) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin <0.01 EU/µg). |
| Application References(PubMed link indicates BioLegend citation) | Leo O, et al. 1987. P. Natl. Acad. Sci. USA 84:1374. (IP, Activ, Block) Kruisbeek AM, et al. 1991. In Current Protocols in Immunology. 3.12.1. (Activ) Duke RC, et al. 1995. Current Protocols in Immunology. 3.17.1. Salvadori S, et al. 1994. J. Immunol. 153:5176. (WB) Payer E, et al. 1991. J. Immunol. 146:2536. (IF) Jacobs H, et al. 1994. Eur. J. Immunol. 24:934. (CMCD) Vossen ACTM, et al. 1995. Eur. J. Immunol. 25:1492. (Activ) Henrickson M, et al. 1995. Transplantation 60:828. (Deplete) Kinnaert P, et al. 1996. Transpl. Int. 9:386. (Deplete) Han WR, et al. 1999. Transpl. Immunol. 7:207. (Deplete) Miescher GC, et al. 1989. Immunol. Lett. 23:113. (Block) Terrazas LI, et al. 2005. Intl. J. Parasitology. 35:1349. (Activ) Ko SY, et al. 2005. J. Immunol. 175:3309. Podd BS, et al. 2006. J. Immunol. 176:6532. (IHC-F) Tilley SL, et al. 2007. J. Immunol. 178:3208. (IHC-F) Wang W, et al. 2007. J. Immunol. 178:4885. (Activ) Xiao S, et al. 2007. J. Exp. Med. 204:1691. Chappaz S, et al. 2007. Blood doi:10.1182/blood-2007-02-074245. (FC) PubMed. Curtsinger JM, et al.2005. J. Immunol. 175:4392. PubMed Guo Y, et al. 2008. Blood 112:480. PubMed Kenna TJ, et al. 2008. Blood 111:2091. Perchonock CE, et al. 2007. J. Immunol. 179:1768. PubMed Perchonock GE, et al. 2006. Mol. Cell. Biol. 26:6005. PubMed Kanaya T, et al. 2008. Am. J. Physiol. Gastrointest. Liver Physiol. 295:G273. PubMed de Koning BA, et al. 2006. Int. Immunol. 18:941. PubMed Schulteis RD, et al. 2008. Blood 295:G273. PubMed Qi Q, et al. 2009. Blood 114:564. PubMed Helmersson S, et al. 2013. Am J Pathol. 9440:123. Pubmed Wu S, et al. 2014. Clin Vaccine Immunol. 21:156. PubMed Yan J, et al. 2014. Vaccine. 32:2833. PubMed Guiterrez DA, et al. 2014. Diaebetes. 63:3827. PubMed Shi YF, et al. 1991. J Immunol. 146:3340. (Apop) |
|---|
| Product Citations | Palacios-Arreola M, et al. 2017. Sci Rep. 10.1038/s41598-017-10135-1. PubMed Saha D et al. 2017. Cancer cell. 32(2):253-267 . PubMed Wiedemann SJ, et al. 2022. Cell Metab. 34:991. PubMed Hao H, et al. 2023. Nat Biomed Eng. . PubMed Zhou L, et al. 2022. PLoS Negl Trop Dis. 16:e0010851. PubMed Ge Y, et al. 2022. iScience. 25:105437. PubMed Fan R, et al. 2023. J Immunother Cancer. 11: . PubMed Issa N, et al. 2023. Leukemia. :. PubMed Roberts JL, et al. 2022. Bone. 157:116310. PubMed Leonardi I, et al. 2022. Cell. 185:831. PubMed Potempa M, et al. 2022. J Immunol. 208:1742. PubMed Miao L, et al. 2020. Theranostics. 0.7625. PubMed Zhou J, et al. 2019. Immunity. 50:403. PubMed Fachi JL et al. 2019. Cell reports. 27(3):750-761 . PubMed Mitroulis I et al. 2018. Cell. 172(1-2):147-161 . PubMed Fu B et al. 2017. Immunity. 47(6):1100-1113 . PubMed Meng J, et al. 2011. Biol Reprod. 85:254. PubMed Wei H, et al. 2021. Malar J. 20:89. PubMed Earnest JT, et al. 2021. Cell Reports. 35(1):108962. PubMed Chikina AS, et al. 2020. Cell. 183:411. PubMed Rao S, et al. 2017. Cell. 168(3):503-516.e12. PubMed Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed Yang X, et al. 2019. Oncotarget. 10:4180. PubMed Dai B, et al. 2022. Theranostics. 12:7603. PubMed Anastasiou M, et al. 2021. JCI Insight. 6:. PubMed Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed Kohn M, et al. 2021. Front Immunol. 580594:12. PubMed Uchil PD et al. 2018. Cell host & microbe. 25(1):87-100 . PubMed Maston LD, et al. 2017. Am J Physiol Lung Cell Mol Physiol. 312:L609. PubMed Fantauzzi MF, et al. 2021. ERJ Open Res. 7: . PubMed Kong YW, et al. 2020. Nat Commun. 3.322222222. PubMed Colliou N, et al. 2018. Gut Microbes. 9:279. PubMed Cong J et al. 2018. Cell metabolism. 28(2):243-255 . PubMed Yin Q, et al. 2021. Proc Natl Acad Sci U S A. 118: . PubMed Noah AC, et al. 2020. J Appl Physiol (1985). 473:128. PubMed Grzelak A, et al. 2018. Int J Mol Sci. 19:. PubMed Wang W, et al. 2020. Immunity. 51(6):1102-1118.e7.. PubMed Ekeke CN, et al. 2020. J Thorac Cardiovasc Surg. S0022-5223:33337. PubMed Bayik D, et al. 2020. Cancer Discov. 1.256944444. PubMed Zhang C, et al. 2020. Cell Rep. 32:108206. PubMed Qi S et al. 2016. eLife. 5 pii: e14756. PubMed Calcinotto A, et al. 2018. Nat Commun. 9:4832. PubMed Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed Shoji M, et al. 2012. Biochem Biophys Res Commun. 425:89. PubMed Kim S, et al. 2021. Elife. 10:. PubMed Shen M, et al. 2022. Nat Cancer. 3:60. PubMed Ni J, et al. 2020. Immunity. 52(6):1075-1087.e8. PubMed Yang S, et al. 2022. J Exp Med. 219:. PubMed Otvos B, et al. 2021. Clin Cancer Res. 27:2038. PubMed Koelwyn GJ, et al. 2020. Nat Med. 1452:26. PubMed Kim M, et al. 2018. Immunity. 49:151. PubMed Baomei Wang et al. 2019. Cell reports. 26(6):1614-1626 . PubMed Sakamoto K, et al. 2021. Immunity. 54:2321. PubMed Stephens WZ, et al. 2021. Cell Rep. 37:109916. PubMed Yuan M, et al. 2022. Oxid Med Cell Longev. 2022:5479491. PubMed Fujii T, et al. 2021. Bone Res. 9:4. PubMed Zhang H, et al. 2021. Cell Reports. 35(6):109096. PubMed Celik H, et al. 2018. Cancer Cell. 34:741. PubMed Barbet G, et al. 2018. Immunity. 48:584. PubMed Zhang X, et al. 2021. Nat Commun. 12:4536. PubMed Mah-Som AY, et al. 2021. Cell Reports. 35(9):109209. PubMed Brown ZJ, et al. 2018. Cell Death Dis. 0.805555556. PubMed Bommareddy PK, et al. 2019. J Biol Methods. 6:2. PubMed Zhong M, et al. 2022. Cell Death Dis. 13:671. PubMed Schmit T, et al. 2022. Cell Rep. 38:110456. PubMed Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed Rivera CA, et al. 2022. Immunity. 55:129. PubMed Habener A, et al. 2021. J Allergy Clin Immunol. 147:2281. PubMed Campisi L, et al. 2016. Nat Immunol. 10.1038/ni.3512. PubMed Bonaccorsi-Riani E, et al. 2015. PLoS One. 10: 0136106. PubMed Ge Y, et al. 2020. Mucosal Immunol. 13:34. PubMed Tsai S, et al. 2018. Cell Metab. 28:922. PubMed Hodgson R, et al. 2022. Commun Biol. 5:1216. PubMed |
|---|
| RRID | AB_1877171 (BioLegend Cat. No. 100329) AB_1877170 (BioLegend Cat. No. 100330) |
|---|
| Structure | Ig superfamily, forms CD3/TCR complex with CD3δ, γ and ζ subunits and TCR (α/β and γ/δ), 20 kD |
|---|
| Distribution | Thymocytes (differentiation dependent), mature T cells, NK-T cells |
|---|
| Function | TCR signal transduction, T cell activation, antigen recognition |
|---|
| Ligand/Receptor | Peptide antigen/MHC-complex |
|---|
| Cell Type | NKT cells, T cells, Thymocytes, Tregs |
|---|
| Biology Area | Immunology |
|---|
| Molecular Family | CD Molecules, TCRs |
|---|
| Antigen References | 1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press. 2. Davis MM. 1990. Annu. Rev. Biochem. 59:475. 3. Weiss A, et al. 1994. Cell 76:263. |
|---|
| Gene ID | 12501 |
|---|
| UniProt | View information about CD3epsilon on UniProt.org |
|---|
| Clone | 145-2C11 |
|---|
| Regulatory Status | RUO |
|---|
| Other Names | CD3ε, T3, CD3 |
|---|
| Isotype | Armenian Hamster IgG |
|---|
